Dr. Jónas Einarsson, M.D, Chairman of the board
is the CEO of The Radium Hospital Research Foundation, and chairman of Oslo Cancer Cluster. Einarsson was responsible for the start up of the first private hospital in Norway, Oslo Private Sykehus. Einarsson sits on the board of several Norwegian Biotech companies. 

Mr. Stein Annexstad, MBA
Mr. Annexstad is an investor with considerable experience in the life science industry at both management and board level.

Jostein Dalland, is the Managing Director of Birkeland Innovasjon. He was earlier head of sales and marketing in Aker Biomarine, and CEO of Natural ASA. 

Dr. Kjetil Taskén, M.D., Ph.D., Dr. Taskén is Professor of Medicine and Director of the Biotechnology Centre at the University of Oslo. He is also a founder of Lauras AS, a biotech company developing therapeutic products for the treatment of HIV/ AIDS, and other immunodeficiency conditions.  

Dr. Eva Steiness, M.D., Ph.D., has been Professor of Clinical Pharmacology at the University of Århus, research director at Lundbeck AS and CEO of Zealand Pharma AS in Denmark. She runs her own consulting company.

Mr. Stig Aune, MBA,  has been a financial analyst and also the CFO of several industrial companies. He is now with the investment company Dag Dvergsten AS. 

Mr. Svenning Torp, Ph.D., is the CEO of Forskningsparken (Oslo Science Park), and also represents Springfondet, a seed fund owned 50% by the Science Park.